180 related articles for article (PubMed ID: 30191729)
1. Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma.
Yoon JS; Kim G; Lee YR; Park SY; Tak WY; Kweon YO; Park JG; Lee HW; Han YS; Ha HT; Chun JM; Jang SY; Hur K
Biomark Med; 2018 Oct; 12(10):1105-1114. PubMed ID: 30191729
[TBL] [Abstract][Full Text] [Related]
2. Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma.
Zhuang L; Xu L; Wang P; Meng Z
PLoS One; 2015; 10(2):e0117274. PubMed ID: 25642945
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.
Liang H; Ai-Jun J; Ji-Zong Z; Jian-Bo H; Liang Z; Yong-Xiang Y; Chen Y
Anticancer Drugs; 2019 Feb; 30(2):186-194. PubMed ID: 30418194
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
5. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
6. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
7. High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis.
Zhu Y; Zhou C; He Q
J Int Med Res; 2019 Jan; 47(1):383-390. PubMed ID: 30394818
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
Lin T; Lin Z; Mai P; Zhang E; Peng L
Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
[TBL] [Abstract][Full Text] [Related]
9. Expression and significance of microRNA-183 in hepatocellular carcinoma.
Liang Z; Gao Y; Shi W; Zhai D; Li S; Jing L; Guo H; Liu T; Wang Y; Du Z
ScientificWorldJournal; 2013; 2013():381874. PubMed ID: 24222732
[TBL] [Abstract][Full Text] [Related]
10. Roles of microRNA-330 and Its Target Gene ING4 in the Development of Aggressive Phenotype in Hepatocellular Carcinoma Cells.
Hu X; Feng Y; Sun L; Qu L; Sun C
Dig Dis Sci; 2017 Mar; 62(3):715-722. PubMed ID: 28050784
[TBL] [Abstract][Full Text] [Related]
11. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
13. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
15. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.
Chen L; Jiang M; Yuan W; Tang H
J Invest Surg; 2012 Jun; 25(3):156-61. PubMed ID: 22583011
[TBL] [Abstract][Full Text] [Related]
16. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
Zhang C; Xia R; Zhang B; Wang H
BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
Hung CL; Yen CS; Tsai HW; Su YC; Yen CJ
BMC Cancer; 2015 Oct; 15():665. PubMed ID: 26453548
[TBL] [Abstract][Full Text] [Related]
18. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-203 Increases Cell Radiosensitivity via Directly Targeting Bmi-1 in Hepatocellular Carcinoma.
Shao Y; Zhang D; Li X; Yang J; Chen L; Ning Z; Xu Y; Deng G; Tao M; Zhu Y; Jiang J
Mol Pharm; 2018 Aug; 15(8):3205-3215. PubMed ID: 29906128
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
Yu L; Zhang J; Guo X; Li Z; Zhang P
Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]